Calcium, a healthcare marketing agency, announced the formation of the Integrated Strategy Group, a unit within the agency that brings together multiple disciplines to create next-generation strategies powered by richer insights, greater analytic rigor, and a stronger emphasis on customer engagement and activation. The unit will be led by Managing Partner and Chief Strategy Officer, Steve Hamburg, who stated in a release, “getting strategy right is a precondition of getting everything else right—which is why our capability is now state of the art.”

The Group brings together highly skilled leaders across the disciplines of medicine and science; social and behavioral science; insight generation and synthesis; customer segmentation, journey mapping, and experience strategy; and omnichannel engagement and activation. Besides Hamburg, leaders of the Integrated Strategy Group include Liz Gopaul, EVP, Engagement and Social; Lauren Lazar, MD, EVP, Medical Director; Lynn Nezin, PhD, SVP, Brand Strategy; and Tim Wisniewski, SVP, Brand Planning. This existing staff will also be further augmented by new talent—across disciplines—in order to meet client needs.

Clockwise from top left: Steve Hamburg, Lauren Lazar, Lynn Nezin, Liz Gopaul, and Tim Wisniewski.

In a press release, Calcium CEO Judy Capano said the new Integrated Strategy Group will “further elevate Calcium’s strategic prowess, reflecting our conviction that powerful insights, ideas, and innovations are at the heart of everything we do for clients.”

Greg Lewis, Calcium President, added “nothing ever stands still in our industry, and under Steve Hamburg’s strong leadership, our Integrated Strategy Group is advancing the art and science of strategy.”

Ads

You May Also Like

Healthcare Highlights

LABEL CHANGES Over-the-counter medication labels contain a seemingly infinite amount of microscopic words that ...

Healthcare Watch November 2022

Patient Pages: PatientPoint Reveals Patients Are Anxious About Talking with Doctors After surveying 2,005 ...

Healthcare Highlights

RELAPSE VACCINATION The FDA granted investigational new drug approval to the Mayo Clinic for ...